Zinc compounds (C07F3/06)

etal complexes of octa-4,5-[4-(1-methyl-1-phenylethyl)phenoxy]phthalocyanine as luminescent materials and dyes for polymeric materials and method of their production // 2641743
FIELD: chemistry.SUBSTANCE: metal complexes of octa-4,5-[4-(1-methyl-1-phenylethyl)phenoxy]phthalocyanine having luminescent and dyeing properties, the formula specified in the description are proposed. The method of producing the specified metal complexes includes the interaction of 4,5-dichloropropionitrile with 4-cumylphenol in the presence of potassium carbonate in dimethylformamide for 8.0-8.5 hours at 85-90°C. After stopping the heating, the reaction mass is poured into water, the precipitate is filtered, washed with isopropanol and dried at 80-90°C. The resulting 4,5-di[4-(1-methyl-1-phenylethyl)phenoxy]phthalonitrile is fused to the metal salt at 155-200°C.EFFECT: producing these metal complexes from available raw materials with increased yield when expanding their range.2 cl, 18 dwg, 10 ex
etal complexes of octa-4,5-(4-sulfophenylsulfanyl)phthalocyanine with copper, zinc, and cobalt // 2640303
FIELD: chemistry.SUBSTANCE: invention relates to metal complexes of octa-4,5-(4-sulfophenylsulfanyl)phthalocyanine with copper, zinc, and cobalt of the general formula , M = Cu, Zn, Co.EFFECT: these metal complexes have a colouring power with respect to woollen and silk fibres.13 dwg, 8 ex
ethod of producing complex acid salts of divalent metals of dicarboxylic acids // 2638157
FIELD: chemistry.SUBSTANCE: method of producing complex acid salts of divalent metal dicarboxylic acids of general formula: Me(AcH)2⋅nH2O, where Me is a divalent metal atom, Ac is an anion of the dicarboxylic acid, H is hydrogen, n is 0-8, is carried out by neutralisation in an aqueous medium, with an oxide of the general formula MeO, where Me is a divalent metal atom, where high, more than 95 wt %, purity of the final product is provided by the molar concentration of the dicarboxylic acid and the divalent metal oxide in the aqueous solution in a ratio of 2.005 to 2.1:1. The synthesis is carried out in such a way that a constant, equal to the original, ratio between all components of the reaction is maintained in the reaction volume. Suitable acids are succinic, fumaric, L-aspartic, L,D-aspartic acids, and as oxides - calcium oxide, magnesium oxide, zinc oxide.EFFECT: improved method.7 cl, 8 ex
Complex of zinc acetate with 1-propargylimidazol with anti-hypoxic activity // 2632682
FIELD: pharmacology.SUBSTANCE: invention is a complex of bis(1-propargylimidazole)zinc diacetate, which has antihypoxic properties under conditions of acute hypoxia (hypobaric, hemic, hypoxia with hypercapnia).EFFECT: antihypoxic effect is superior to that of etimerzole, mexidol, nooglutil and hypoxen.1 tbl
Zinc acetate complex with 3-hydroxypyridine with anti-hypoxic activity under conditions of acute exogenous hypoxia // 2631496
FIELD: pharmacology.SUBSTANCE: invention relates to a zinc acetate complex with 3-hydroxypyridine of the formula: .EFFECT: metal complex has antihypoxic activity under conditions of acute exogenous hypoxia.1 tbl
ethod of obtaining porous coordination polymer mof-177 // 2629361
FIELD: chemistry.SUBSTANCE: method involves mixing salt-zinc acetate and 1,3,5-trifenilbenzol-p,p,p'-tricarboxylic acid, made mass ratio of 2.5:1-4.5, in the presence of the solvent, in sufficient quantity to dissolve the reactants, the subsequent heating the reaction mixture obtained under the influence of microwave radiation and allocation of the target product. As a solvent, a mixture of water and polar organic cosolvent, taken at a weight ratio of 1:1-4, is used, respectively. The process is carried out at atmospheric pressure and heating the reaction mixture to a temperature of 120-140°C under the influence of microwave radiation with power up to 200 Watts.EFFECT: invention simplifies technology polymer MOF-177, improving the performance of the process while maintaining high output.2 cl, 1 tbl, 5 ex
Oral care products, including zinc oxide and trimethylglycine // 2628540
FIELD: pharmacology.SUBSTANCE: group of inventions refers to oral care compositions, consisting of a mixture of zinc oxide and trimethylglycine (TMG), where the TMG is included into the composition in the form of hydrohalogenide, and zinc oxide and TMG form soluble complexes, selected from zinc-TMG-hydrohalogenide complexes, zinc-hydrohalogenide complexes and mixtures, where the hydrohalogenide is selected from hydrofluoride, hydrochloride and hydrobromide, as well as to a method for tooth enamel erosion treatment or mitigation, biofilm and bacterial plaque reduction, gingivitis reduction, tooth decay and cavities formation reduction, dentin hypersensitivity reduction, including application of such composition to the teeth, zinc oxide application together with the TMG in the form of hydrohalogenide during oral care composition production.EFFECT: creation of a complex, capable of yielding a solution which precipitates when diluted.15 cl, 4 ex, 6 tbl
9-antracenates of lanthanides, showing luminescent properties, and organic leds on its basis // 2626824
FIELD: chemistry.SUBSTANCE: described 9-antracenates of lanthanides formula M (ant)3, where M is lanthanum and lanthanides, besides promethium Pm and cerium Ce, which exhibit luminescent properties. The complexes of ytterbium, erbium and neodymium luminesce in the infrared spectrum range, the lutetium and terbium complexes in the blue spectrum area, and the gadolinium complex Gd - in the green spectrum area. The organic light-emitting diode is also described, which includes the thin film of the mentioned lanthanide anthracenate as the emission layer. The quantum yield of the ytterbium complex is 1.3%, which is the high value for the lanthanide complexes, emitting in the infrared range. The lifetime of the neodymium, erbium, and ytterbium complexes is 17, 13, and 52 microseconds, which is the rather large value for the complexes of these metals.EFFECT: expansion of the lanthanide complexes range with luminescence and high efficiency of electroluminescence due to the ion luminescence of lanthanides, as well as the expansion of the organic light-emitting diodes range.9 cl, 2 tbl, 20 ex

Organozinc complex, preparation and application thereof // 2620376
FIELD: pharmacy.SUBSTANCE: method comprises interaction (A) of at least one organomagnesium complex with (B) at least one coordinating compound in combination with zinc ions and lithium ions and halide ions, at that, the said halide ions are selected from chloride, bromide and iodide. The said coordinating compound is represented by the formula (I): R1Tq, where each T is -CO2- or -O-, R1 represents an alkyl group containing from 4 to 8 carbon atoms, and "q" is a positive integer. Options of organozinc reagents preparation and coordinating zinc complex are also proposed.EFFECT: these reagents can be used for preparation of organic compounds by cross-coupling Negishi reactions, or by reaction of oxidative aldehyde or ketone addition.15 cl, 1 dwg, 3 tbl, 8 ex
ethod of obtaining the coordination connection of zinc with nicotine acid // 2618533
FIELD: chemistry.SUBSTANCE: invention relates to a process for preparing nicotinate hydrate of zinc by electrolysis of aqueous organic solution of nicotinic acid with zinc electrodes at a constant current, comprising separating the resulting precipitate, washing the precipitate and drying it. The mass ratio of acetonitrile: ethanol: water: nicotinic acid: electrolyte is 55.13:19.73:5.00: 1.00:0.05, the electric current density is 3-5 mA/cm2.EFFECT: invention simplifies the process for preparing the zinc complex compound with nicotinic acid and simultaneously reduce the time required.3 tbl, 1 ex
Zinc complexes 2-(n-tozylaminobenzylidene)-2'-iminoalkyl pyridines, liuminescent activity // 2616979
FIELD: chemistry.SUBSTANCE: invention relates to bis-[2-(N-tozylaminobenzylidene)-2'-iminoalkylpyridinato] zinc (II) complexes of general formula I or chloro-[2-N-tozylaminobenzylidene)-2'-iminoalkylpyridinato] zinc (II) of the general formula II where n=1 or 2. Metal-complex compounds I, II possess photoluminescent properties, emit in the blue region of the spectrum and can be used in the creation of light-emitting organic diodes (OLED) of white and visible light as electroluminescent layers.EFFECT: improved properties.3 dwg, 1 tbl, 4 ex

Borated derivatives of fluorinated bacteriochlorines and their metal complexes with antitumor activity // 2615770
FIELD: pharmacology.SUBSTANCE: invention relates to borated derivatives of fluorinated bacteriochlorines and their metal complexes. The compounds have the general formula I , wherein M=2H, X=Cs (Ia), M=Cu, X=Cs (Ib), M=Zn, X=Cs (Ic), M=Ni, X=Cs (Id), M=Pd, X=Cs (Ie), M=2H, X=Na (If), M=Cu, X=Na (Ig), M=Zn, X=Na (Ih) M=Ni, X=Na (Ii), M=Pd, X=Na (Ij).EFFECT: compounds can be used as an antitumor agent for boron neutron-capturing therapy and photodynamic cancer therapy.4 dwg, 10 ex

Zinc-lysine complex // 2615131
FIELD: hygiene.SUBSTANCE: invention relates to zinc-lysine complex of formula [Zn(C6H14N2O2)2Cl]+Cl-. Invention also discloses composition of personal hygiene mean, oral care composition, method of reducing sweating and body odor, method of destroying bacteria, method of producing zinc-lysine complex and its application.EFFECT: zinc-lysine complex possesses antibacterial and antiperspirant properties.24 cl, 1 dwg, 3 tbl, 2 ex

?-form zinc-phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an ?-form zinc- phthalocyanine nanowire/phenothiazine, and method for preparing thereof // 2602698
FIELD: medicine.SUBSTANCE: present invention relates to α-form zinc-phthalocyanine nanowires (ZnPc NWs) with increased water solubility and water dispersibility, to a composite of α-form zinc-phthalocyanine nanowire/phenothiazine, a method for preparing the same and a photosensitizer comprising the same and a pharmaceutical composition comprising the same for preventing or treating cancers. Obtained using the disclosed method α-form zinc-phthalocyanine nanowires have increased solubility and dispersibility in water in a concentration of 100 to 140 mg/L.EFFECT: since disclosed nanowires or the composite exhibit photothermal and photodynamic traits in single molecule, they are very useful for the development of a multifunctional molecular system and can also be usefully applied to light therapy of cancers due to their good light therapeutic effects; also, the composite of alpha-form zinc-phthalocyanine nanowire/phenothiazine itself can exhibit fluorescence to facilitate the introduction of an imaging system, so that diagnosis and treatment can be simultaneously performed using a single substance.11 cl, 6 ex, 33 dwg

Bis-[2-(substituted benzylidene)-3',4'-dimethoxyphenylethyliminate]zinc(ii), having luminescent activity // 2602263
FIELD: chemistry.SUBSTANCE: invention relates to novel compounds metal-chalate-bidentate azomethine ligands of 2-N-tosylaminobenzaldehyde and 2-hydroxybenzaldehyde and aralkylamines, specifically to bis-[2-(N-tosylaminobenzylidene)-3′,4′-dimethoxyphenylethyliminate]zinc(II) and bis-[2-(hydroxybenzylidene)-3′,4-dimethoxyphenylethyliminate]zinc(II) of formula I:where X=NTs (a), X=O (b), Ts=-SO2-C6H4-CH3-p. Novel complexes of zinc - bis-[2-(N-tosylaminobenzylidene)-3′,4′-dimethoxyphenylethyliminate]zinc(II) and bis-[2-(hydroxybenzylidene)-3′,4′-dimethoxyphenylethyliminate]zinc(II), exhibit photoluminescent properties in violet and blue spectrum λfl=427 nm and λfl=442 nm with quantum fluorescence output 0.33 and 0.36 respectively and have thermal stability.EFFECT: compounds can be used in designing organic light-emitting diodes (OLED) of white and visible light as electroluminescent layers.1 cl, 1 dwg, 5 ex

ethod for synthesis of heterothreenuclear coordination compound based on iminodiacetic acid salicylidenhydrazone // 2591197
FIELD: physics.SUBSTANCE: invention relates to a method for synthesis of heterothreenuclear coordination compound based on iminodiacetic acid salicylidenhydrazone. Method involves adding salicylic aldehyde to hydrazide iminodiacetic acid solution in methanol, holding obtained precipitate for at least of 12 hours, addition of copper (II) acetate monohydrate to obtained suspension, dissolving obtained compound in minimum amount of pyridine, adding water, washing precipitate with water and alcohol, drying in air to constant mass. Then suspension of binuclear complex of copper with iminodiacetic acid salicylidenhydrazone in ethanol is added with pyridine until dissolution of precipitate, added to obtained solution equivalent amount of zinc or nickel acetate, stirring mixture while heating for at least of 1 hour, obtained solution is filtered. In one day product is separated by filtration, washed with alcohol and air dried to constant mass.EFFECT: invention enables to obtain heterothreenuclear coordination compounds, which are promising in designing new magnetic and optical materials, catalyst systems, low-molecular models of metalloenzymes, etc.1 cl, 1 ex
Complexonates of ethylenediamine-β-propionic acids with divalent metals: copper, zinc, nickel and cobalt, and methods for production thereof // 2582680
FIELD: chemistry.SUBSTANCE: invention relates to chemistry of ethylenediamine propionic acids and directly relates to complexonates of ethylenediamine-β-propionic acids with divalent metals: copper, zinc, nickel and cobalt. Complexonate has general formula (R1R2NCH2CH2NR3R4)nM, where M=Cu(II), Zn(II), Ni(II), Co(II); R1, R2=H; R3=H, CH2CH2COO; R4=CH2CH2COO; n=1.2. Also disclosed are methods of producing complexonates.EFFECT: said complexonates can be used as chelates in medicine, agriculture and other fields.4 cl, 8 ex

Antidote for carbon monoxide // 2581467
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to carbon monoxide antidote, which is 1-butyl-5-oxyiminopergidropyrimidin-2,4,6-trionata zinc acetate with structural formula: .EFFECT: invention can be used for treating and preventing of carbon monoxide (CO) poisoning, as well as for treatment of hypoxic states of various aetiology.1 cl, 9 tbl, 6 ex

Bis(5-amino-1,4-dioxo-1,2,3,4-tetrahydrophthalazin-2-yl)zinc, method for producing it, based pharmaceutical composition, based therapeutic agents, method of treating skin diseases and method of treating gastritis // 2577849
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine, particularly to a compound representing bis(5-amino-1,4-dioxo-1,2,3,4-tetrahydrophthalazin-2-yl)zinc of formula (I) . Use of the compound of formula (I) (versions), a method for producing it, a based pharmaceutical composition, methods of treating skin diseases and gastritis are also presented.EFFECT: invention enables producing the compound of formula (I), which provides relieving or eliminating negative consequences of skin and mucosal injuries.63 cl, 27 dwg, 6 tbl, 13 ex

ethod for obtaining organotitanium zinc-containing glycerohydrogel // 2574579
FIELD: chemistry.SUBSTANCE: method includes the interaction of glycerol and purified butylorthotitanate with the molar ratio of 11.75:1 respectively with the following distillation of butanol from the mixture at a temperature from 98°C to 102°C in vacuum (residual pressure from 0.01 to 0.02 MPa), addition of the calculated amount of a 20% sodium hydroxide solution with the further determination of titanium content in the reaction mass, addition of a calculated amount of purified water, required for the dilution of the reaction mass, addition of a 0.2% zinc oxide solution and a 10% citric acid solution. The reaction mass is mixed for 15 minutes after the addition of each component. Vacuum is switched off, the obtained semi-product is cooled to the temperature from 35°C to 40°C, a 10% hydrochloric acid solution is added to pH from 4.5 to 5.6, with the further mixing for 30 minutes and pouring into a prepared container, where it is kept for 20-40 minutes until a gel-like finished product is formed.EFFECT: invention makes it possible to reduce the technological process, improve the quality and efficiency of the finished product, eliminate the release of metal titanium under the impact of light and increase the solubility of the finished product in water with the preservation of conducting activity through skin and mucosa.2 tbl, 1 ex

ethod of producing amino acid chelate compounds, amino acid chelate compounds and use of amino acid chelate compounds // 2567057
FIELD: chemistry.SUBSTANCE: invention relates to a method of producing amino acid chelate compounds. The method is characterised by that metal oxides and/or metal carbonates and/or metal sulphates and/or metal chlorides and/or metal hydroxides in solid form are mechanically activated and the activated metal oxides and/or metal carbonates and/or metal hydroxides and/or metal sulphates and/or metal chlorides are brought together with amino acids in solid form and converted to amino acid chelate compounds in a solid-phase reaction. The metal is copper, and/or zinc, and/or manganese, and/or iron, and/or magnesium, and/or calcium, and/or nickel, and/or cobalt. The invention also discloses amino acid chelate compounds whose particles have a finely dispersed needle-like structure, and use of the amino acid chelate compounds.EFFECT: invention provides a simple and stable method which is suitable for industrial production of amino acid chelate compounds.30 cl, 2 dwg, 3 ex

[n,n'-bis(2-tosylaminobenzylidene)diaminodipropyliminate]metal, possessing luminiscent activity // 2562456
FIELD: chemistry.SUBSTANCE: invention relates to novel compounds in series of metallochelates of tetradentate azomethine ligands of 2-tosylaminobenzaldehyde and aliphatic diamines, namely [N,N'-bis(2-tosylaminobenzylidene)diaminodipropyliminate]zinc and cadmium of formula I , where M=Zn, Cd.EFFECT: invention makes it possible to obtain novel compounds, demonstrating photoluminiscent properties in blue area of spectrum and possessing higher quantum outputs and thermal stability.3 ex

Organometallic skeleton materials based on 2,5-furandicarboxylic or 2,5-thiophenecarboxylic acid // 2561603
FIELD: chemistry.SUBSTANCE: invention relates to a porous organometallic skeleton material. The material contains at least a double-coordination organic compound, coordinationally connected with at least one metal ion and representing a derivative of 2,5-furandicarboxylic or 2,5-thiophenecarboxylic acid. At least one metal ion is a ion of a metal, selected from the group, including aluminium, magnesium and zinc. The concept "derivative" means that 2,5-furandicarboxylic acid or 2,5-thiophenedicarboxylic acid can be present in the skeleton material in a partially or completely deprotonated form. Also claimed are: moulded product, method of obtaining the skeleton material, application of the skeleton material or the moulded product.EFFECT: invention makes it possible to obtain the skeleton material, which can be applied for gas accumulation and separation of gas from a gas mixture.9 cl, 3 dwg, 6 ex

Electroluminescent device // 2551675
FIELD: electricity.SUBSTANCE: invention relates to the electroluminescent device. The device contains hole injecting layer, hole transport layer, electronic block layer, active luminescent layer based on luminescent substance, hole-block layer, electronic transport layer, electronic injecting layer. As the luminescent substance it contains bis[2-(N-tosylamino)-benzylidene-2-aminopyridinato] of zinc (II) of formula I: .EFFECT: electroluminescent device based on chelate complexes of zinc of azometin derivants 2-(N-tosylaminobenzaldehyde), emitting in yellow-green spectrum.6 dwg, 1 tbl, 1 ex

Heterogenic sensibiliser and method of water photoremediation // 2538261
FIELD: chemistry.SUBSTANCE: invention relates to chemistry and chemical technology, namely to synthesis of modified silicagels, containing molecules of substituted phthalocyanines covalently bound with them, and their application for water photoremediation. Method of water photoremediation with application of radiation of visible range in presence of oxygen and heterogenic sensibiliser of general formula: , where R=H is either SPh; X is anion; n=4-8; M=Zn, AlL, GaL, SiLz; L=Cl, OH; M=1-4.EFFECT: invention makes it possible to carry out efficient purification of water from bacteriological contamination.2 cl, 3 tbl, 11 ex

Zinc complexes of 5-[2-hydroxy(tosylamino)benzylidene-amino]-2-(2-tosylaminophenyl)-1-alkylbenzimidazoles, having photoluminescent activity // 2532904
FIELD: chemistry.SUBSTANCE: invention relates to zinc complexes of 5-[2-hydroxy(tosylamino)benzylidene-amino]-2-(2-tosylaminophenyl)-1-alkylbenzimidazoles of general formula I , where R = alkyl C1-C6; X=O, ; .EFFECT: compounds I exhibit luminescent properties and can be used as luminophores for producing organic light-emitting diodes emitting white and visible light.18 ex

Zinc and cadmium complexes of tetradentate azomethines of 2-tosylaminebenzaldehyde, possessing luminiscent activity // 2532642
FIELD: chemistry.SUBSTANCE: invention relates to novel metal chelates, namely to zinc and cadmium complexes of tetradentate azomethines of 2-tosylaminebenzaldehyde and dioxydiamines of formula I , where m=2-4, n=2-4, M=Zn, Cd.EFFECT: metal-complex compounds I demonstrate photoluminiscent properties in the blue spectrum region and can be used as an electroluminescent layer in the creation of organic light-emitting diodes (OLED) of white and visible light.4 cl, 5 ex
Silicon-zinc-containing glycerohydrogel, possessing wound healing, regenerative and antibacterial activity // 2520969
FIELD: chemistry.SUBSTANCE: claimed is a silicon-zinc-containing glycerohydrogel, possessing a wound healing, regenerative and antibacterial activity, a composition of which corresponds to formula kSi(C3H7O3)4·ZnC3H6O3·xC3H8O3·yH2O, where 1≤k≤4, 7≤x≤26, 20≤y≤100, obtained by interaction of tetraglycerolate of silicon in excess of glycerol Si(C3H7O3)4·xC3H8O3, where 0,5≤x≤10, monoglycerolate of zinc in abundance of glycerol ZnC3H6O3·6C3H8O3 and water in molar ratio Si(C3H7O3)4:ZnC3H6O3:C3H8O3:H2O equal to (1÷4):1:(7÷26):(20÷100) at a temperature of 20-40°C and intensive mixing.EFFECT: claimed silicon-zinc-containing glycerohydrogel possesses the wound healing, regenerative and antibacterial activity, is simple to obtain and convenient in application.1 tbl, 6 ex

Bis[2-(n-tozylamino)benzyliden-4'-dimethylaminophenyliminato]zinc(ii) and based on it electroluminiscent device // 2518893
FIELD: chemistry.SUBSTANCE: invention relates to novel compounds in a series of chelate complexes of zinc with azomethine derivatives, namely to bis[2-(N-tozylamino)benzyliden-4'-dimethylaminophenyliminato]zinc(II) of formula I Also claimed is electroluminescent device.EFFECT: invention makes it possible to obtain compounds, demonstrating electroluminescent properties with high brightness.2 cl, 3 dwg, 1 tbl, 2 ex

Zinc dimeric complexes of crown-containing styryl phenanthrolines as optical sensors on cations of alkali-earth and heavy metals and method of their obtaining // 2516656
FIELD: chemistry.SUBSTANCE: described are 15-crown-5- and dithia-18-crown-6-containig 2-methyl-9-styryl phenanthrolines of formula: where as optical sensors on cations of calcium, barium and lead. Claimed compounds are obtained by interaction of ligand of 15-crown-5 or dithia-18-crown-6-containing 2-methyl-9-styryl phenanthroline with zinc perchlorate in acetonitrile with irradiation with red light.EFFECT: complexes possess properties of highly efficient fluorescent sensors on cations of calcium, barium and lead, which make it possible to visually determine metal cation.2 cl, 2 tbl, 2 ex

Zinc complex of asymmetric ethylenediamine-n,n-dipropyonic acid dichloride and method of its obtaining // 2511271
FIELD: chemistry.SUBSTANCE: invention relates to zinc complex of asymmetric ethylenediamine-N,N-dipropyonic acid dichloride of formula Also claimed is method of its obtaining. Complex can be applied for solution of problems, associated with the necessity to introduce Zn2+ in chelate form instead of its mineral salts, as well as to serve as initial product for synthesis of other chemical compounds of series of polydentate ligands, in particular asymmetric ethylenediamine-N,N-dipropyonic acid.EFFECT: obtaining zinc complex of asymmetric ethylenediamine-N,N-dipropyonic acid dichloride.4 cl, 4 dwg, 3 ex

Antibodies and pharmaceutical compositions containing them, which are suitable for inhibition of activity of metalloproteins // 2503682
FIELD: biotechnologies.SUBSTANCE: invention refers to a compound having general formula (I), where: m and n are independent integer numbers of 1 to 6; each of X1-X3 and Y1-Y3 is O; each of R1-R3 is independently chosen from a group consisting of hydrogen or alkyl; and R is O-(CH2)x-C(-O)NR'-(CH2)y-NHR'. Besides, x and y are independent integer numbers of 1 to 6; and R' is chosen from the group consisting of hydrogen and alkyl. In addition, an antibody containing an antigen recognition area, use of the compound, pharmaceutical composition, use of the antibody, method for MMP-2 or MMP-9 activity inhibition in a sample and a composition for determining MMP-2 or MMP-9 are proposed.EFFECT: invention allows obtaining compounds that are able to inhibit MMP-2 or MMP-9 activity.11 cl, 16 dwg, 4 tbl, 11 ex

olecular complexes of zinc and cadmium bis(1-phenyl-3-methyl-4-formyl-5-pyrazolonate) with amino-derivatives of nitric heterocycles, having luminescent activity // 2485128
FIELD: chemistry.SUBSTANCE: invention relates to molecular complexes of zinc and cadmium bis(1-phenyl-3-methyl-4-formyl-5-pyrazolonate) with amino-derivatives of nitric heterocycles of general formula (I) (NH2-Het)n, where NH2-Het is 1-aminoisoquinoline, 3-aminoquinoline, 6-aminoquinoline, 5-amino-4,6-dimethylquinoline, 2-aminopyridine, 2-amino-5-bromopyridine, 3-amino-5-methylisoxazole, 2-amino-1-ethylbenzimidazole, M is Zn, Cd, n=1, 2.EFFECT: molecular complexes of formula (I) exhibit luminescent properties in the blue region of the spectrum and can be used as phosphors for making organic light-emitting diodes of white and visible light.14 ex

Zinc (ii) bis{3-methyl-1-phenyl-4-[(quinoline-3-imino)-methyl]1-h-pyrazol-5-onato) and electroluminescent device based thereon // 2470025
FIELD: chemistry.SUBSTANCE: invention relates to electroluminescent substances and specifically to zinc (II) bis{3-methyl-1-phenyl-4-[(quinoline-3-imino)-methyl]1-H-pyrazol-5-onato} of general formula I . Also disclosed is an electroluminescent device which contains zinc (II) bis{3-methyl-1-phenyl-4-[(quinoline-3-imino)-methyl]1-H-pyrazol-5-onato} of general formula I.EFFECT: compound exhibits electroluminscent properties in the yellow spectral region with high brightness.2 cl, 4 ex

ethod of producing dialkylzinc and dialkylaluminium monohalide // 2465277
FIELD: chemistry.SUBSTANCE: method involves reaction of a zinc halide with trialkylaluminium containing a hydride and trialkylaluminium with one or more polymerised alkyl groups. Content of hydride in trialkylaluminium ranges from 0.01 wt % to 0.10 wt %. After reaction, dialkylzinc containing not more than 10 ppmw aluminium is separated from the reaction products and dialkylaluminium monohalide containing not more than 10 ppmw zinc is then separated.EFFECT: invention enables to obtain dialkylzinc and dialkylaluminium monohalide of high purity and with high output.7 cl, 2 dwg, 1 tbl, 5 ex

Tetra-4-[(4'-carboxy)phenylamino]phthalocyanine metal complexes // 2463324
FIELD: chemistry.SUBSTANCE: invention relates to novel substituted metal phthalocyanines, which can be used as direct and acid dyes for dyeing cotton and protein fibre. Disclosed are tetra-4-[(4'-carboxy)phenylamino]phthalocyanine metal complexes of formula, where M=Cu, Ni, Zn.EFFECT: metal phthalocyanines expand the colour gamma of the current light-blue copper tetra-4-carboxyphthalocyanine, which is the closest on structure and application, to a blue-green and green colour.6 dwg, 5 ex

ethod of producing zinc meso-tetra-aminotetrabenzoporphyrinate // 2458928
FIELD: chemistry.SUBSTANCE: invention relates to a method of producing zinc meso-tetra-aminotetrabenzoporphyrinate. The method involves reaction of a phthalic anhydride with aminoacetic acid to obtain N-carboxymethylphthalimide, from which while heating with zinc oxide, a zinc salt of N-carboxymethylphthalimide is obtained. The obtained salt reacts with phthalimide at high temperature from 240°C to 320°C for 2-2.5 hours, followed by treatment of the reaction mass with hydrazine hydrate in pyridine solution at boiling point thereof for 1.5-2 hours.EFFECT: high safety of the process owing to prevention of formation of dangerous and toxic acetic and nitric acids, high cost-effectiveness of the process and obtaining an end product of high purity.3 dwg

Sensitising agent and method for photodecontamination of water // 2448135
FIELD: chemistry.SUBSTANCE: disclosed are novel phthalocyanines, which are quaternised derivates of zinc and aluminium tetra(3-thiophenyl)phthalocyanines of formula MPc(SPh)4Rn, where: MPc(SPh)4Rn is zinc or aluminium tetra(3-thiopheny)phthalocyanine, M=Zn, AlX; X=Cl, HO, , , n=4-9. The disclosed phthalocyanines are sensitising agents for formation of singlet oxygen under the effect of visible light. Also disclosed is a method of treating water using said phthalocyanines or mixture thereof with acridine, rhodamine or phenothiazine dyes and visible light in the presence of oxygen.EFFECT: efficient treatment of water from bacterial contamination.2 cl, 1 dwg, 3 tbl, 7 ex

ethod for synthesis of organoelement compounds // 2440355
FIELD: chemistry.SUBSTANCE: disclosed is a method for synthesis of compounds of general formula R1-M1-AdzLix (I) by reacting compound R1 - A (III) with element M1, where M1 denotes Mn, Cu, Zn, Li, Bi, in the presence of lithium salts. Also disclosed is a method for synthesis of a compound of general formula R1 m - M3 - TnzLix (II) by reacting compound R1 - A (III) with an M3-containing compound in the presence of lithium salts and in the presence of an elementary metal M2 - Li, Na, Mg. Metal M3 can be selected from Al, Mg, B.EFFECT: improved method.14 cl, 1 tbl

1-allylimidazole derivatives // 2430090
FIELD: chemistry.SUBSTANCE: invention relates to novel derivatives of 1-allylimidazole with metal salts , where R denotes allyl, E denotes a metal, e.g. Zn (II) or Co (II), An denotes chlorine or acetate, n equals 2.EFFECT: novel 1-allylimidazole derivatives having antihypoxic activity are obtained.1 cl, 7 tbl, 2 ex

Binuclear coordination compounds of biologically active d-elements with aliphatic thiols as agents for increasing efficiency of medicinal drugs // 2417999
FIELD: chemistry.SUBSTANCE: in the compound of formula I, M denotes identical or different metal atoms selected from a group comprising: Pd, Fe, Mn, Co, Ni, Cu, Zn or Mo, R1 and R2 independently denote hydrogen, amino, hydroxyl, carboxy, cyano, C1-12alkyl, C2-12alkenyl, C2-12alkynyl, C1-12alkoxy, C1-12alkylamino, C1-12alkoxycarbonyl, C1-12alkylamido,arylamido. Alkyl groups in the said substitutes may in turn be substituted with one or more of the following groups: hydroxyl, oxo, carboxy, amino or amido, R3-R10 independently denote hydrogen, or NHR3R4 and NHR5R6, taken together, and(or) NHR7R8 and NHR9R10, taken together, denote a ligand (or ligands) containing one or more donor aliphatic or aromatic nitrogen atoms and which occupy the cis-position near metal (M) atoms. The invention also discloses a pharmaceutical composition, use of the compound to prepare a medicinal drug and a therapeutic treatment method.EFFECT: obtaining compounds capable of boosting efficiency of medicinal drugs.25 cl, 17 ex, 23 tbl

Electroluminescent device // 2408648
FIELD: chemistry.SUBSTANCE: electroluminescent device has a hole injection layer, a hole transport layer, an active luminescent layer based on electroluminescent substance of formula I , a hole blocking layer, an electron transport layer and an electron injection layer.EFFECT: high luminance of devices emitting in the green spectral region.1 ex

1-alkenylimidazole derivatives // 2397175
FIELD: chemistry.SUBSTANCE: invention relates to 1-alkenylimidazole derivatives of general formula 1 , where R is vinyl, allenyl or isopropenyl, R1 is hydrogen or methyl, E is Zn (II) or Fe(III), An is chlorine or acetate, n equals 1, 2 or 4, except compounds where R is vinyl, R1 is hydrogen, E is Zn(II), An is chlorine or acetate and n equals 2.EFFECT: compounds have antihypoxic properties for different types of hypoxia.5 ex, 8 tbl

Zinc bis[2-(tosylamino)benzylidene-1n-alkyliminates] having luminescent activity // 2395512
FIELD: chemistry.SUBSTANCE: invention relates to zinc bis[2-(tosylamino)benzylidene-N-alkyliminates] of general formula , where Ts = tosyl, R=C7-C18 alkyl.EFFECT: compounds exhibit luminescent properties and can be used as luminophors for making white and visible light organic light-emitting diodes.3 cl, 2 ex

Electroluminescent material, containing organic luminescent substance // 2368641
FIELD: physics.SUBSTANCE: electroluminescent material is described, consisting of an electron injection layer, an active luminescent layer based on a metal chalate complex, a hole transport layer and a hole injection layer. The luminescent substance is in form of new zinc complexes based on sulphonylamino derivatives of 2-phenylbenzoxazole or 2-phenylbenzothiazole. The hole transport layer of the material is preferably a mixture of triphenylamine oligomers.EFFECT: electroluminescent material with high moisture resistance, high resistance to crystallisation and high thermal stability.9 cl, 5 ex

Zinc mezo-triphenyltetra-[-4-(п-triphenylmethylphenoxybenzo)] monoazaporphyrinate // 2355697
FIELD: chemistry.SUBSTANCE: invention concerns novel compound of zinc mezzo-triphenyltetra-[-(п-triphenylmethylphenoxybenzo)]monoazaporphyrinate.EFFECT: possible application as fat-soluble green colourant for polymers, as material for thin film microelectronics, as catalyst, and in other scientific and technical fields.1 cl, 1 ex, 1 dwg
ethod of obtaining ethylenediammonium bis(1-hydroxyethane-1,1-diphosphonato(2-))cuprate(+2), zincate(+2) and nickelate(+2) // 2352575
FIELD: chemistry.SUBSTANCE: invention relates to obtaining etyheleneammonium bis(1-hydroxyethane-1,1-diphosphonato(2-))cuprate (+2), etyheleneammonium bis(1-hydroxyethane-1,1-diphosphonato(2-)) zincate(+2) and etyheleneammonium bis(1-hydroxyethane-1,1-diphosphonato(2-)) nickelate(+2) and can be used for processing toxic wastes of obtaining metal coatings - waste electrolytes of galvanic copper, zinc and nickel plating, waste solutions of chemical nickel plating and copper plating. Products, obtained by said method, can be used for preparation of electrolytes, metal corrosion inhibitors, for obtaining various copper, zinc and nickel compounds, including catalysts of organic and inorganic substance synthesis. Claimed method includes using liquid industrial wastes, containing metal(+2), ethyleneammonium and/or anion of 1-hydroxyethane-1,1-diphosphonic acid as reagents. Target products are obtained by crystallisation from reaction water solution with separation of sediment from solution, process is carried out at temperature from (-5) to 105°C and atmospheric pressure. Method allows to obtain pure crystalline products with yield up to 98%, to reduce expenditures on environment protection.EFFECT: method simplification and increase of its manufacturability.7 cl, 9 ex

Alkylthiosubstituted phtalocyanides, their medicinal forms and method of photodynamic therapy // 2340615
FIELD: chemistry.SUBSTANCE: as photosensibilizers emulsions of alkylthiosubstituted phalocyanides of general formula , where R1=R4=Cl, R2=R3=n-C10H21S, M=Zn or R1=t-C4H9S, R2=R3=R4=H, M=HH or R1=t-C4H9S, R2=R4=H, R3=t-C4H9, M=HH or R1=R3=t-C4H9S, R2=R4=H, M=HH or R1=R2=R3=R4=t-C4H9S, M=HH or R1=R4=Cl, R2=R3=t-C4H9S, M=Zn, in water solution of Proxanol 268 are suggested.EFFECT: elaboration of highly selective and efficient photosensibilizers for application in photodynamic therapy of tumours.3 cl, 18 ex, 4 tbl, 9 dwg

Zinc meso-trans-dihexadecyltetrabenzoporphyrinate // 2326883
FIELD: chemistry.SUBSTANCE: invention concerns a new compound, zinc meso-trans-dihexadecyltetrabenzoporphyrinate .EFFECT: compound can be applied as a fat-soluble green colorant for solution dyeing of paraffin and polyethylene.1 cl, 2 ex, 2 dwg
ethod for preparing pharmacopoeia bis-(1-vinylamidazole)-zinc diacetate // 2311419
FIELD: organic chemistry, chemical technology.SUBSTANCE: invention proposes an improved method for synthesis of bis-(1-vinylimidazole)-zinc diacetate representing a complex compound of zinc diacetate with 1-vinylimidazole and known as medicinal preparation acizol. Acizol is an effective antidote and antihypoxic agent of the broad spectrum of effect. Method for synthesis of 1-vinylimidazole metal with zinc diacetate of the composition 2:1 involves carrying reaction in the absence of solvent and using available commercial zinc diacetate of the formula Zn(OCOCH3)2 x 2 H2O in the stoichiometric mole ratio 1-vinylimidazole : salt in the range from 2.9:1 to 2:1, and synthesized pure product is isolated by water distilling off or its azeotropic mixture with 1-vinylimidazole. Method provides excluding the dehydration step of parent zinc salt from technological process and to decrease consumption of used reagent 1-vinylimidazole significantly, Invention provides significant reducing energetic and industrial consumptions, simplifying and decreasing cost of process and retaining the quantitative yield of highly pure pharmacopoeia acizol preparation.EFFECT: improved method of synthesis.4 ex